Bill Gates Says AstraZeneca, Johnson & Johnson, Novavax COVID-19 Vaccines All Likely To Prove 'Very Efficacious And Safe' By February
Bill Gates Says AstraZeneca, Johnson & Johnson, Novavax COVID-19 Vaccines All Likely To Prove 'Very Efficacious And Safe' By February
Microsoft Corporation (NASDAQ:MSFT) co-founder Bill Gates expressed optimism on the efficacy of COVID-19 vaccines made by various drugmakers in an interview with CNN on Sunday.
What Happened: The billionaire told CNN’s Fareed Zakaria that while vaccines from Pfizer Inc (NYSE:NVAX) vaccines.
“I'm optimistic that by February, it's very likely they'll all prove very efficacious and safe,” said Gates.
The tech billionaire expects the vaccine to “start to cut the numbers down” in spring.
Why It Matters: Pfizer’s vaccine is 95% effective in preventing COVID-19, while Moderna Inc said its vaccine has the same efficacy.
Pfizer and its German partner BioNTech SE (NASDAQ:BNTX) filed for emergency use authorization on Friday.
The vaccine made by the duo could reportedly be available for the high-risk populations in the United States by the middle or end of December.
Moderna is also expected to file for EUA soon and has released its interim Phase 3 results.
AstraZeneca’s vaccine was found to trigger similar immune responses in both young and elderly patients, as per findings of a phase two trial.
Older adults and people with pre-existing conditions are at the greatest risk of developing serious symptoms of COVID-19, according to the co-author of the phase two study, Dr. Maheshi Ramasamy.
Gates' foundation has backed the development of a vaccine for COVID-19 and said its entire focus was on fighting the pandemic.
Price Action: On Friday, Pfizer shares closed 1.41% higher at $36.70, Moderna Shares closed 5.22% higher at $97.61, AstraZeneca shares closed 2.35% higher at $55.30, Novavax shares closed 0.17% higher at $86.55, and Johnson & Johnson shares closed 0.53% lower at $146.36.
Photo courtesy: UK Department for International Development via Flickr
Microsoft Corporation (NASDAQ:MSFT) co-founder Bill Gates expressed optimism on the efficacy of COVID-19 vaccines made by various drugmakers in an interview with CNN on Sunday.
What Happened: The billionaire told CNN’s Fareed Zakaria that while vaccines from Pfizer Inc (NYSE:NVAX) vaccines.
發生了什麼事： 這位億萬富翁告訴 CNN 的法瑞扎卡里亞，雖然疫苗來自 輝瑞公司 (紐約證券交易所:NVAX) 疫苗.
“I'm optimistic that by February, it's very likely they'll all prove very efficacious and safe,” said Gates.
蓋茨說：「我很樂觀地認為，到二月份，他們很可能都會證明非常有效和安全。」
The tech billionaire expects the vaccine to “start to cut the numbers down” in spring.
這位科技億萬富翁預計該疫苗將在春季「開始減少數字」。
Why It Matters: Pfizer’s vaccine is 95% effective in preventing COVID-19, while Moderna Inc said its vaccine has the same efficacy.
Pfizer and its German partner BioNTech SE (NASDAQ:BNTX) filed for emergency use authorization on Friday.
The vaccine made by the duo could reportedly be available for the high-risk populations in the United States by the middle or end of December.
據報導，該二人製造的疫苗可能在 12 月中旬或下旬為美國的高風險人群提供。
Moderna is also expected to file for EUA soon and has released its interim Phase 3 results.
Moderna 也預計將很快就向歐盟提出申報，並已發布其中期第三階段結果。
AstraZeneca’s vaccine was found to trigger similar immune responses in both young and elderly patients, as per findings of a phase two trial.
阿斯利康的疫苗被發現可以觸發類似的免疫反應 年輕和老年患者, 根據第二階段試驗的結果。
Older adults and people with pre-existing conditions are at the greatest risk of developing serious symptoms of COVID-19, according to the co-author of the phase two study, Dr. Maheshi Ramasamy.
根據第二階段研究的共同作者馬赫希·拉馬薩米博士（Maheshi Ramasamy）博士的說法，老年人和患有預先存在疾病的人最大的風險是發生 COVID-19 的嚴重症狀。
Gates' foundation has backed the development of a vaccine for COVID-19 and said its entire focus was on fighting the pandemic.
蓋茨基金會為 COVID-19 疫苗的開發提供了支持，並表示其 整個重點都是對抗大流行病。
Price Action: On Friday, Pfizer shares closed 1.41% higher at $36.70, Moderna Shares closed 5.22% higher at $97.61, AstraZeneca shares closed 2.35% higher at $55.30, Novavax shares closed 0.17% higher at $86.55, and Johnson & Johnson shares closed 0.53% lower at $146.36.
價格行動： 上周五，輝瑞股票收盤上漲 1.41%，報 36.70 美元，收盤 5.22% 上漲 5.22%，報 97.61 美元，阿斯利康股份收盤 2.35% 上漲 5.30 美元，報 55.30 美元，上漲 0.17%，報 86.55 美元，強生公司股價下跌 0.53%，報 146.36 美元。
Photo courtesy: UK Department for International Development via Flickr
相片由 Flickr 提供：英國國際發展部
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧